Effects of Rocuronium on Myocardial Oxygen Supply-Demand in Patients with Rheumatic Heart Disease During Induction of Anaesthesia

CHEN Guo,LI Yu,LI Qian,LV Pei-lin,ZHOU Rong-hua,LIU Bin
2009-01-01
Abstract:Objective:To evaluate the effects of rocuronium on myocardial oxygen supply-demand in patients with rheumatic heart disease (RHD) during induction.Methods:86 patients of either sex (ASA status Ⅲ-Ⅳ;New York Heart Association classes Ⅱ-Ⅲ) scheduled for valve replacement surgery were included in this randomized clinical trial (RCT).Swan-Ganz catheter was placed via right internal jugular vein before the induction of anaesthesia.Anaesthesia was induced with midazolam 0.05-0.1mg.kg-1 and fentanyl 10-15 μg·kg-1.The patients were randomized to receive either rocuronium 0.6 mg·kg-1 (group R,n=42) or vecuronium 0.1 mg·kg-1 (group V,n=41) to facilitate tracheal intubation when bispectral index (BIS) value dropped to 60.All data were recorded at the time before anaesthesia (Tb),loss of consciousness (Ts),administration of muscle relaxant (Tm),1 min after administration of muscle relaxant (T1),when train-of-four stimulation (TOF) reached 0 (T2) and 1,2,3,4,5,7,10 min after tracheal intubation (T3-9).Results:Heart rate (HR) increased by 17.4%-13.5%,systemic arterial systolic pressure (SAP) increased by 16.94%-14.3%,mean arterial systolic pressure (MAP) increased by 15.1%-13.2% and product of heart rate and arterial systolic pressure(RPP) increased 22.67%-13.96% respectively during 5 minutes after intubation as compared with baseline in group R,which were significantly higher than those in group V during 5 minutes after intubation (P0.05).Conclusion:An intubation dose of rocuronium should be used cautiously in patients with rheumatic heart disease (ASA status Ⅲ-Ⅳ;NYHA classes II-Ⅲ).
What problem does this paper attempt to address?